HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.

Abstract
The microenvironment is known to critically modulate tumor progression, yet its role in regulating treatment response is poorly understood. Here we found increased macrophage infiltration and cathepsin protease levels in mammary tumors following paclitaxel (Taxol) chemotherapy. Cathepsin-expressing macrophages protected against Taxol-induced tumor cell death in coculture, an effect fully reversed by cathepsin inhibition and mediated partially by cathepsins B and S. Macrophages were also found to protect against tumor cell death induced by additional chemotherapeutics, specifically etoposide and doxorubicin. Combining Taxol with cathepsin inhibition in vivo significantly enhanced efficacy against primary and metastatic tumors, supporting the therapeutic relevance of this effect. Additionally incorporating continuous low-dose cyclophosphamide dramatically impaired tumor growth and metastasis and improved survival. This study highlights the importance of integrated targeting of the tumor and its microenvironment and implicates macrophages and cathepsins in blunting chemotherapeutic response.
AuthorsTanaya Shree, Oakley C Olson, Benelita T Elie, Jemila C Kester, Alfred L Garfall, Kenishana Simpson, Katherine M Bell-McGuinn, Emily C Zabor, Edi Brogi, Johanna A Joyce
JournalGenes & development (Genes Dev) Vol. 25 Issue 23 Pg. 2465-79 (Dec 01 2011) ISSN: 1549-5477 [Electronic] United States
PMID22156207 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Etoposide
  • Doxorubicin
  • Cathepsins
  • Paclitaxel
Topics
  • Animals
  • Antineoplastic Agents (pharmacology, therapeutic use)
  • Cathepsins (metabolism)
  • Cell Line, Tumor
  • Doxorubicin (pharmacology, therapeutic use)
  • Drug Interactions
  • Drug Resistance, Neoplasm
  • Etoposide (pharmacology, therapeutic use)
  • Female
  • Lung Neoplasms (prevention & control, secondary)
  • Macrophages (pathology)
  • Mammary Neoplasms, Animal (drug therapy, enzymology, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Neoplasm Invasiveness
  • Paclitaxel (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: